Memantine improves social impairment in youths with autism spectrum disorder

Twelve weeks of treatment with memantine resulted in significant improvement in social impairment among youths with autism spectrum disorder, a placebo‐controlled trial has found. Memantine also did not result in significantly more adverse events compared with placebo. Study results were published online Oct. 1, 2025, in JAMA Network Open .